Clinical Trial Update: Famotidine and Antacids for Treatment of Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicates recruitment for evaluating famotidine with antacids to treat dyspepsia and gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastroesophageal Reflux Disease

Drugs mentioned

• Calcium carbonate (Calcium carbonate)
• Famotidine (famotidine)
• Magnesium hydroxide (magnesium hydroxide)

Snippet

Sponsor: Stony Brook University | Conditions: Dyspepsia, GERD | Phase 4 | Status: RECRUITING